Xiang Li1, Yupeng Wang2, Qiankun Shi1, Nuo Zhen1, Jin Xue1, Jingsheng Liu1, Dongfang Zhou2, Hao Zhang1. 1. College of Food Science and Engineering, National Engineering Laboratory for Wheat and Corn Deep Processing, Jilin Agricultural University, Changchun, Jilin 130118, China. 2. Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
Abstract
Current cancer treatment is not only limited to monotherapy but is also influenced by limited drug delivery options. Combined chemokinetic-photokinetic therapy has great promise in enhancing anticancer effects. Meanwhile, zein has superior self-assembly properties and can be loaded with photosensitizers. Herein, the targeted multifunctional nanoparticles based on zein/hyaluronate acid (HA)/tannin (TA)/Cu2+ loaded with IR780 (ZHTC@IR780) are constructed for synergetic cancer therapy by chemo-dynamic therapy (CDT) and photodynamic therapy (PDT). There is experimental proof that ZHTC@IR780 nanoparticles (NPs) can relieve the tumor hypoxic microenvironment by catalytic decomposition of endogenous H2O2 to O2 and further react with O2 to produce toxic 1O2 with 808 nm laser irradiation. The glutathione oxidase-like effects of ZHTC@IR780 NPs can generate Fenton-like Cu+ ions and deplete GSH for efficient hydroxyl radical (•OH) production. In addition, CDT combined with PDT enhances the antitumor effect. Photodynamic therapy can cause immunogenic cell death, increase calreticulin eversion, release histone with high mobility, and promote apoptosis of tumor cells.
Current cancer treatment is not only limited to monotherapy but is also influenced by limited drug delivery options. Combined chemokinetic-photokinetic therapy has great promise in enhancing anticancer effects. Meanwhile, zein has superior self-assembly properties and can be loaded with photosensitizers. Herein, the targeted multifunctional nanoparticles based on zein/hyaluronate acid (HA)/tannin (TA)/Cu2+ loaded with IR780 (ZHTC@IR780) are constructed for synergetic cancer therapy by chemo-dynamic therapy (CDT) and photodynamic therapy (PDT). There is experimental proof that ZHTC@IR780 nanoparticles (NPs) can relieve the tumor hypoxic microenvironment by catalytic decomposition of endogenous H2O2 to O2 and further react with O2 to produce toxic 1O2 with 808 nm laser irradiation. The glutathione oxidase-like effects of ZHTC@IR780 NPs can generate Fenton-like Cu+ ions and deplete GSH for efficient hydroxyl radical (•OH) production. In addition, CDT combined with PDT enhances the antitumor effect. Photodynamic therapy can cause immunogenic cell death, increase calreticulin eversion, release histone with high mobility, and promote apoptosis of tumor cells.
Cancer is a common disease that poses
a serious risk to human health
and has become a leading cause of death worldwide. At present, the
main clinical treatments for cancer are surgical resection, chemotherapy,
and radiation therapy.[1−4] The tumor microenvironment (TME) of solid tumors with severe hypoxia,
high H2O2 levels, and glutathione (GSH) overexpression
promotes tumor proliferation and metastasis.[5,6] Therefore,
it is difficult to completely cure tumors with monotherapy, and combined
therapy with adjustment of TME is of great significance for ablating
primary tumors and preventing tumor metastasis.[7−9] Among these,
comprehensive treatments such as photodynamic therapy (PDT) and chemical
dynamic therapy (CDT) utilize specific intracellular chemical reactions
to produce cytotoxic reactive oxygen species (ROS), including singlet
oxygen (1O2), hydroxyl radicals (•OH) and superoxide anion (•O2–). Although photodynamic therapy has the advantages of light pain,
small side effects, and low systemic toxicity, the active oxygen generation
efficiency of photodynamic therapy is low due to the hypoxic TME and
rapid energy attenuation.[10,11] In recent studies,
combined therapies such as PDT/photothermal therapy (PTT), PDT/chemotherapy,
and PDT/immunotherapy have been used to overcome monotherapy’s
insufficient tumor suppression effect.[1,6,7,12−19] From the abovementioned, we know that under the tumor microenvironment,
Fenton or Fenton-like reactions can generate •OH
and O2 at the same time, which indicates that CDT can improve
the hypoxia deficiency in PDT and enhance its therapeutic effects,
while UV–vis or near-infrared laser irradiation can increase
the efficiency of the Fenton reaction to produce •OH and improve the antitumor effects of CDT.[20−22] Jia et al.,
for example, developed a smart TME responsive nanocatalyst by employing
Fe–Mn layered double hydroxides (FeMn-LDH) as an efficient
photothermal nanocarrier to load mesoporous silica and Ce6 covalently
coated upconversion nanoparticles (UCSP) for multimodal imaging and
directed therapy.[16] This work achieved
excellent oxygen-elevated PDT, enhanced PTT and CDT synergistic therapy,
and real-time monitoring of the therapeutic effect.Nanoparticles
are widely used in the development of controlled
drug delivery systems as well as in the diagnosis and treatment of
cancer due to their good physicochemical and biological properties
such as size, hydrophobicity, and surface charge.[23] The smaller size of nanoparticles allows them to be used
as carriers of drugs into the body, improving their bioaccessibility.
Protein-based nanomaterials offer advantages such as biodegradability
and biocompatibility.[24] Zein is the main
storage protein in corn endosperm,[25] and
it contains hydrophobic, neutral, and polar amino acids. It is typically
only soluble in an aqueous 60–95% ethanol solution.[26] Many researchers have used its poor solubility
to induce self-assembly into nanoparticles by antisolvent precipitation
and complexation with hydrophilic polysaccharides to improve storage
stability in water. Hyaluronic acid is a biocompatible polysaccharide
composed of d-glucuronic acid and N-acetyl-d-glucosamine, which can form hydrogen bonds in solution and
can act as a stabilizer and targeting agent.[27] It has been demonstrated that hyaluronic acid-coated zein core–shell
nanoparticles can achieve HNK-targeted delivery to overexpressing
4T1 breast cancer cells, overexpressing CD44 with high encapsulation
efficiency, enhanced stability, and slow release properties, making
them suitable as an efficient drug delivery system.[28]As a water-soluble polyphenol widely distributed
in the plant kingdom,
tannins have a wide range of restorative, therapeutic, and pharmacological
properties,[29] and the catechol or gallic
acyl groups in their structure can provide chelating sites for metal
ions and have a strong chelating effect on them.[30] Also, due to the potential binding sites between tannins
and hydrophobic amino acids in zein, such as proline and phenylalanine,[31] recent research has used intermolecular interactions
between zein and tannic acid to modify the model protein β-galactosidase
and encapsulate it in spore powder outer wall capsules, where stronger
binding of zein/TA to the drug improved the protein’s sustained
delivery.[32] In short, tannins and zein
are suitable as efficient and stable composite nanomaterials for drug
delivery.Here, the zein is used as a carrier for the IR780
stretcher. A
targeted multifunctional nano-drug ZHTC@IR780 NPs was prepared for
the first time, which achieved synergistic cancer therapy by chemodynamic
therapy, phototherapy, and immunotherapy (Scheme ). First, ZHTC@IR780 NPs with catalase-like
activity could react with endogenous H2O2 to
generate O2 for accelerating 1O2 production
under 808 nm laser irradiation. Meanwhile, multivalent elements (Cu1+/2+) of ZHTC@IR780 NPs demonstrated superior OH generation
ability via Fenton-like reaction to realize CDT and consume overexpressed
GSH in TME for modulating the tumor’s antioxidant capability
via glutathione peroxidase-like activity. The IR780 acts as a significant
photosensitizer when stimulated by NIR light and could be activated
to produce 1O2 for PDT therapy. Collectively,
the ZHTC@IR780 NPs multivalent elements (Cu1+/2+) exhibit
Fenton-like, glutathione (GSH) peroxidase-like, and catalase-like
activity. In addition, the ZHTC@IR780 NPs under 808 nm laser irradiation
show remarkable tumor-killing ability by phototherapy due to their
excellent photothermal conversion efficiency and cytotoxic super 1O2 generation performance. This work provides an
innovative strategy for the synergistic and integrative treatment
of cancer, and zein-based nanomedicine drugs may have great potential
as a promising candidate for cancer therapeutics.
Scheme 1
Mechanism of Nanoparticles
Inducing Tumor Cell Apoptosis
Experimental Section
Materials and Method
Materials
All reagents and solvents were obtained commercially
and used without further purification. Zein (≥98%), sodium
hyaluronate (97%), sodium carboxymethyl cellulose (CMC, USP), tannic
acid (98%), and IR780 (95%) were obtained from Sigma-Aldrich. Copper
chloride dihydrate (CuCl2·2H2O), 1,3 diphenylisobenzofuran
(DPBF), and methylene blue trihydrate (MB) were purchased from J&K
Chemical Co. The mouse colon cancer cell CT26 was obtained from the
Chinese Academy of Sciences’ Institute of Biochemistry and
Cell Biology and was cultured in DMEM (10% fetal bovine serum; 5%
CO2 at 37 °C). Other chemicals were purchased from
Sinopharm Chemical Reagent Co., Ltd., China.
Instrumentation
The morphologies of nanoparticles were
obtained by transmission electron microscopy (TEM, JEM1011, Japan).
The particle size and zeta potential were performed by the Zetasizer
Nano ZS90 system (Malvern, UK). X-ray photoelectron spectroscopy (XPS)
spectra were obtained using the Thermo Scientific ESCALAB 250 XI.
Real-time measurement of O2 concentration in a solution
was performed by a portable dissolved oxygen meter (JPBJ-608, Rex,
INESA Scientific Instruments). The UV–visible absorption was
obtained by a UV-1800 spectrophotometer (Shimadzu, Japan). The cell
fluorescence imaging experiments were carried out using a confocal
laser scanning fluorescence microscope (CLSM, FV1000, Olympus, Japan).
The concentration of released Cu of CMSNs and the concentration of
Cu in blood samples and tissues were measured by inductively coupled
plasma-optical emission spectrometry (ICP-OES, Xseries II, Thermo
Scientific, USA). It was used to analyze the targeting ability of
Zein-HA-TA-Cu@IR780 nanoparticles.
Synthesis of Zein-HA-TA-Cu@IR780 (ZHTC@IR780) Nanoparticles
The nanoparticle synthesis method was as follows: zein was dissolved
in a 90 v/v % aqueous solution of ethanol (zein, 10 mg/mL) and stirred
for 2 h to be fully dissolved and then used. The low molecular weight
sodium hyaluronate (20 mg) was added to 9 mL of distilled water and
then magnetically stirred at room temperature for sufficiently long
enough time to dissolve. Then, 2 mg of IR780 was dissolved in 1 mL
of dimethyl sulfoxide, and then added to sodium hyaluronate drop by
drop, simultaneously with 1 mL of prepared 10 mg/mL zein solution,
and magnetically stirred for 5 min. The ethanol was then removed by
dialysis for 4 h with a molecular weight cutoff (MWCO) of 3500 Da.
After the end of the dialysis, 100 μL of a tannic acid solution
(24 mM) was added dropwise, and the mixture was stirred for 10 min;
then, 30 μL of a copper chloride dihydrate solution (72 mM)
was added dropwise, and the mixture was further dialyzed for 10 h.
The resulting nanomaterial was then stored at 4 °C. The Zein,
Zein-HA, Zein-HA-TA-Cu, and Zein-CMC-TA-Cu nanoparticles were used
as comparison groups for ZHTC@IR780 nanoparticles. The preparation
method is the same as mentioned above.
pH-Responsive Release of Drug-Loaded Nanoparticles IR780 and
Cu2+ In Vitro
The release of IR780 was performed
as follows: at a certain concentration, 2 mL of the prepared drug-laden
nanoparticles were transferred to a dialysis bag (with an MWCO of
3500 Da). The bag was tied and submerged in 18 mL of PBS solution
in the dialysis solution and placed in a 37 °C shaker at 100
rpm to avoid light. The dialysate was divided into two groups, one
with PBS solution at pH 7.4 and the other with PBS solution at pH
5.0. At regular intervals, 2 mL of dialysate was removed, and 2 mL
of the corresponding pH of PBS solution was added to the dialysate.
The released IR780 content of the removed dialysate was measured by
a UV spectrometer and the cumulative IR780 release was calculated.The Cu2+ release operation was performed as mentioned
above, and the released Cu2+ content of the removed dialysate
was determined by ICP-OES, and the cumulative Cu2+ release
was calculated.
Under vigorous stirring, 3 mL of ZHTC@IR780 nanoparticles (IR780
2.5 μg/mL) and 100 μL of H2O2 (10
mM) were added to 3 mL of water in turn, under vigorous stirring,
and the O2 concentration of the solution was monitored
by a portable dissolved oxygen meter in real time.
Singlet Oxygen (1O2) Detection
Measurement of Singlet Oxygen Generation By using the trapping agent
DPBF (Aladdin Regent, Shanghai), which was used to confirm singlet
oxygen by detecting its absorption intensity at 421 nm via UV–vis
spectroscopy, was used to detect the ZHTC@IR780 nanoparticle-enhanced 1O2 generation in the presence of H2O2. Before the detection, the prepared system was irradiated
by an 808 nm laser (0.1 W/cm2) for 5 s. In a typical experiment,
DPBF (0.15 mg/mL) in alcohol was added to the ZHTC@IR780 nanoparticles
solution (3 mL, IR780 2.5 μg/mL). The solution was saturated
with an Ar atmosphere and irradiated with an 808 nm laser (0.1 W/cm2) for 30 min, and the absorption intensity of DPBF at 421
nm was recorded every 5 s. In the control experiments, the solution
was not saturated with the Ar atmosphere. Herein, a hypoxic condition
was achieved by Ar blowing into the solution for 30 min before the
test.
Evaluation of •OH Production
A classical
colorimetric method was used based on the degradation of MB under
the oxidative environment. In brief, ZHTC@IR780 was added into an
aqueous solution containing H2O2 (10 mM) and
MB (15 μg mL–1). After incubation at 37 °C
for various time intervals, the absorption of the abovementioned solutions
at 665 nm was measured to record the degradation of MB.
In Vitro ZHTC@IR780 NPs Assay on GSH Depletion Properties
GSH was detected by DTNB and its UV–vis absorption was measured
at 313 nm and 408 nm. The samples were divided into seven groups:
DTNB group: 10 μL DTNB (2.5 mg/mL) + 990 μL PBS; ZHTC@IR780
group: 80 μL ZHTC@IR780 (1 mg/mL) + 920 μL PBS; GSH group:
10 μL GSH solution (10 mM) + 990 μL PBS; ZHTC@IR780 +
GSH group [80 μL ZHTC@IR780 solution (1 mg/mL) + 10 μL
GSH solution (10 mM) + 910 μL PBS]; GSH + DTNB group: 10 μL
GSH solution (10 mM) + 10 μL DTNB (2.5 mg/mL) + 980 μL
PBS; and ZHTC@IR780 + DTNB group: 80 μL ZHTC@IR780 solution
(1 mg/mL) + 10 μL DTNB (2.5 mg/mL) + 910 μL PBS; except
for the ZHTC@IR780 + GSH + DTNB group, UV–visible spectra were
performed after homogeneous solute mixing for 10 min in all cases.
The ZHTC@IR780 + GSH + DTNB group was operated as follows: first GSH
and ZHTC@IR780 nanoparticles were reacted for 10 min, and then DTNB
solution was added and treated for 10 min, followed by UV–visible
spectroscopy.
Cell Experiment
In this experiment, mouse colon cancer
cells (CT26) were cultured in the DMEM (GIBCO) medium. The DMEM medium
contains 10% fetal bovine serum and 10% penicillin–streptomycin
mixture (100×).
Uptake Analysis
The endocytosis of drug-loaded nanoparticles
by CT26 cells was observed by a laser confocal scanning microscope
(CLSM). The cells were inoculated into a six-well plate and cultured
overnight to make them adhere to the wall. Then, CT26 cells were incubated
with free small molecules IR780, ZHT@IR780, ZHTC@IR780, and ZCTC@IR780
IR780 (the concentration of IR780 is the same: 1 μg/mL) at 37
°C for 4 h and washed with PBS three times.The cells were
stained with 1 mL of the lysosomal green fluorescent probe (Lyso-Tracker,
50 nM) for 40 min, washed three times with PBS, fixed with 4% paraformaldehyde
for 15 min, and washed three times with PBS. Finally, the cells were
stained with DAPI for 8 min, washed with PBS three times, and mounted.
CLSM was used to observe the intensity and position of fluorescence
in cells. DAPI is excited at 405 nm; the lysosomal green fluorescent
probe is excited at 488 nm; IR780 is excited at 555 nm.
Determination of Reactive Oxygen Species
The intracellular
ROS of each group was detected by the DCF-DA probe. Cells from CT26
cells (1 × 105 cells/well) were inoculated into a
six-well plate and cultured overnight to make the cells adhere to
the wall. Then CT26 cells were incubated with the medium solution
of free small molecules IR780, ZHT@IR780, ZHTC@IR780, and ZCTC@IR780
(IR780 concentration: 1 μg/mL) for 4 h, and the light group
was exposed to light (0.1 W/cm2). After 30 min, the abandoned
culture medium was washed with PBS three times, and then, for 20 min,
it was incubated with a serum-free medium containing DCF-DA. Among
them, in the no-light control group, all operations were the same
as in the light group except no light was applied. Finally, we used
a laser confocal scanning microscope to observe the production of
cellular ROS, which was excited with a 488 nm channel, with green
fluorescence indicating ROS production.
In Vitro Cytotoxicity
CT26 cells were seeded in 96-well
plates at a density of 1 × 104 cells per well in DMEM
(100 μL) containing 10% FBS at 37 °C under a 5% CO2 humidified atmosphere or in a hypoxic incubator. After 12
h of incubation, the medium was removed, and then, fresh DMEM with
10% FBS was added. IR780, ZH@ IR780, ZHT@ IR780, and ZHTC@ IR780 were
used at various final concentrations in DMEM (0.3125, 0.62, 1.25,
2.5, and 5.0 g/mL). IR780 (1.0 mM) was dissolved in a little dimethyl
sulfoxide (DMSO) and added to the cell culture medium. To minimize
the influence of DMSO, the final DMSO concentration in the medium
was controlled to less than 0.1%. After 4 h of incubation, excess
unbound materials were washed three times with PBS. The cells were
exposed to an 808 nm laser at a power density of 0.1 W/cm2 for 3 min after adding fresh DMEM into 96-well plates. After 48
h of incubation, for the MTT assay, the MTT solution (20 μL,
5 mg/mL) was added. After incubation for 4 h, the culture medium was
removed. The DMSO solution (150 μL) was added, the plates were
subsequently placed on a microplate oscillator for 10 min, and a microplate
reader was used to determine the final UV absorbance at a detection
wavelength of 490 nm.
In Vitro PDT
CT26 cells were seeded into 24-well plates
and then incubated with PBS, IR780, ZH@IR780, ZHT@IR780, and ZHTC@IR780
(IR780 1 μg/mL) at 37 °C under normoxic or hypoxic conditions.
The hypoxic condition was achieved by incubating the cells in a hypoxic
incubator supplied with a hypoxic gas stream (1% O2, 5%
CO2, and 94% N2) for 4 h. Then, the cells were
exposed to an 808 nm laser at a power density of 0.1 W cm–2 for 60 s. The excess unbound materials were washed three times with
PBS. The DCFH-DA (2′,7′-dichlorodihydrofluorescein diacetate)
ROS Assay Kit was used to detect the ROS generation inside cells.
Western Blot
CT26 cells were incubated in normoxic
or hypoxic conditions. Then, cells were lysed and collected, followed
by mixing with sample buffers and heating at 95 °C for 5 min.
After electrophoresis with 10% SDS-PAGE (sodium dodecyl sulphate-polyacrylamide
gel electrophoresis), proteins were transferred to a polyvinylidene
difluoride (PVDF) membrane. The PVDF membrane was stained with primary
antibodies against HIF-1α (ab190197, Abcam, Cambridge, MA, USA)
to evaluate the degree of hypoxia and against tubulin for the loading
control, and then with a horseradish peroxidase (HRP)-labeled secondary
antibody. The HIF-1α level was monitored by enhanced chemiluminescence
using the Gel Doc system (BioRad).
Immunofluorescence for Cellular Hypoxia
The procedure
for CT26 cell culture is the same as that for the western blot. Following
different treatments, cells were fixed with 4% paraformaldehyde (PFA)
at 37 °C for 20 min and permeabilized with PBS containing 0.2%
Triton X-100 at 37 °C for 1 min. After blocking with PBS containing
0.05% Tween-20 buffer and 5% bovine serum albumin (Sigma) at room
temperature for 120 min, the cells were incubated with primary antibodies
against HIF-1α or calreticulin or PD-L1 in a humidified chamber
at room temperature for 120 min, followed by phalloidin (Rhodamine
Conjugate) at room temperature for 2 h. Images were captured by DeltaVision
SoftWoRx Software (Applied Precision) and processed by deconvolution
and z-stack projection.
Results and Discussion
ZHTC@IR780 NPs Preparation and Characterization
Zein’s
self-assembly ability, driven by hydrophobicity and hydrophilicity,
has been used as a carrier for encapsulation and controlled release
of fat-soluble compounds using a simple antisolvent precipitation
method.[33,34] For a brief moment, zein solution and IR780
solution were dripped into HA solution at the same time. Then, in
order to stabilize the nanoparticles and achieve the synergistic therapy
of chemo-dynamic therapy and photodynamic therapy, tannic acid and
copper dichloride solutions were added drop by drop, respectively.
Finally, the organic solvent was removed by dialysis and ZHTC@IR780
nanoparticles were obtained.The surface morphology of the Zein,
Zein-HA, Zein-HA-TA-Cu, and ZHTC@IR780 nanoparticles was monitored
by TEM. As shown in Figure S1, the nanoparticles
prepared with only Zein components showed aggregation and poor dispersion.
When hyaluronic acid was added, the dispersion of the nanoparticles
was improved. After the addition of tannic acid, metal ion copper,
and photosensitizer IR780 iodide, the size and dispersion of the nanoparticles
did not change significantly, and they still maintained a uniform
spherical structure (Figure A). As determined by dynamic light scattering (DLS) (Figure A), the average size
of fabricated ZHTC@IR780 NPs was approximately 179 nm. In addition,
the effect of nanoparticle components was investigated by the zeta
potential of nanoparticles. As shown in Figure B, when sodium hyaluronate and tannic acid
were added, the absolute value of nanoparticle potential was greater
than 30, indicating that sodium hyaluronate can increase nanoparticle
stability. Furthermore, the potential values of nanoparticles under
different pH conditions were detected. The results showed that the
potentials of nanoparticles were negative under pH 7.4 and pH 6.5,
indicating that they could circulate normally in vivo and meet the
requirements of intravenous injection (Figure C). The size of ZHTC@IR780 NPs stored at
different pH values remained almost unchanged in 72 h, indicating
the good stability of ZHTC@IR780 NPs in solution (Figure D). X-ray photoelectron spectroscopy
(XPS) analysis of ZHTC@IR780 NPs revealed that the Cu existed primarily
in the form of Cu2+ (Figure E,F).
Figure 1
(A) TEM images (inset images) and average particle size
of ZHTC@IR780
nanoparticles. (B) Zein, Zein-HA, Zein-HA-Cu, Zein-HA-TA-Cu nanoparticles,
and zeta potential. (C) Zein, Zein-HA, Zein-HA-TA, Zein-HA-TA-Cu nanoparticles,
and zeta potential under different pH conditions. (D) Storage stability
of the ZHTC@IR780 nanoparticles under different pH conditions. (E,F)
XPS spectra of ZHTC@IR780 nanoparticles.
(A) TEM images (inset images) and average particle size
of ZHTC@IR780
nanoparticles. (B) Zein, Zein-HA, Zein-HA-Cu, Zein-HA-TA-Cu nanoparticles,
and zeta potential. (C) Zein, Zein-HA, Zein-HA-TA, Zein-HA-TA-Cu nanoparticles,
and zeta potential under different pH conditions. (D) Storage stability
of the ZHTC@IR780 nanoparticles under different pH conditions. (E,F)
XPS spectra of ZHTC@IR780 nanoparticles.
pH-Responsive Release of Drug-Loaded Nanoparticles IR780 and
Cu2+ In Vitro
Next, we investigated the release
of IR780 and Cu2+ by ZHTC@IR780 nanoparticles in the blood
circulation microenvironment (pH 7.4) and in the lysosomal microenvironment
(pH 5.0) using dialysis. As shown in Figure A,B, only slow release of IR780 (less than
24%) and Cu2+ (12%) from NPs was observed at pH 7.4 after
48 h of incubation. By contrast, after 48 h of incubation at pH 5,
approximately 57% of IR780 and 84% of Cu2+ were released
into the medium. The results showed that ZHTC@IR780 nanoparticles
had good stability and would not cause systemic toxicity caused by
a large amount of drug released into the blood circulation. It also
indicated that the nanoparticles had good pH response and release
characteristics.
Figure 2
(A) Release profile of IR780 from nanoparticles under
different
pH conditions. (B) Release profile of Cu2+ from nanoparticles
under different pH conditions. (C) Catalytic efficiency of ZHTC@IR780
nanoparticles on H2O2. (D) Catalysis of H2O2 by ZHT@IR780 and ZHTC@IR780 nanoparticles.
(A) Release profile of IR780 from nanoparticles under
different
pH conditions. (B) Release profile of Cu2+ from nanoparticles
under different pH conditions. (C) Catalytic efficiency of ZHTC@IR780
nanoparticles on H2O2. (D) Catalysis of H2O2 by ZHT@IR780 and ZHTC@IR780 nanoparticles.
Photodynamic Chemical Dynamics Detection at the Solution Level
The catalytic ability of nanoparticles to H2O2 was determined using an H2O2 kit. As shown
in Figure C, the catalytic
efficiency of ZHTC@IR780 after 180 min reached 64.58%, which was 47%
higher than that of natural decomposition at 17.58%, indicating that
ZHTC@IR780 nanoparticles had a good ability to catalyze H2O2. Furthermore, by detecting the change of oxygen content
in the solution after the addition of ZHTC@IR780, adding H2O2 at the 10th minute, and comparing it to the PBS group
without copper ions, Figure D shows that ZHTC@IR780 nanoparticles could significantly
improve the decomposition of H2O2 to O2, while the catalytic efficiency of the control group was average.
These experimental results indicate that ZHTC@IR780 NPs could accelerate
H2O2 decomposition to generate O2, which might alleviate tumor hypoxia and provide necessary conditions
for photodynamic therapy.Under the catalysis of ferrous ions
(Fe2+) or other Fenton-like ions,[35−38] Fenton or Fenton-like reactions
can generate oxidative •OH from H2O2. CDT can alleviate the oxygen deficiency in PDT and improve
its therapeutic effect. The generated O2 can increase the
production efficiency of •OH through near-infrared
laser irradiation, thereby enhancing the antitumor effect of CDT.
The Cu of ZHTC@IR780 nanoparticles could result in a Fenton-like reaction,
catalyzing H2O2 to produce O2 and •OH. Furthermore, •OH could degrade
methylene blue (MB), and the production of •OH can
be detected by the change of methylene blue ultraviolet absorption.
In Figure A, the MB
degradation capacity of the ZHTC@IR780 nanoparticles group with additional
H2O2 was assayed, which was obviously elevated
due to more •OH generation. As shown in Figure S2, with the extension of time, the absorption
peak of methylene blue was getting lower and lower, indicating that •OH can be continuously produced to degrade MB. The
results showed that the nanoparticle had good chemical kinetic activity
in vitro.
Figure 3
(A) UV–vis absorption curves of MB solution after different
treatments. (B) In vitro 1O2 assay under anaerobic
conditions, the relative absorbance of DPBF at 410 nm in the solution
changes with time. (C) In vitro 1O2 assay under
aerobic conditions, the relative absorbance of DPBF at 410 nm in the
solution changes with time. (D) Oxidative glutathione-like catalysis
of ZHTC@IR780 nanoparticles.
(A) UV–vis absorption curves of MB solution after different
treatments. (B) In vitro 1O2 assay under anaerobic
conditions, the relative absorbance of DPBF at 410 nm in the solution
changes with time. (C) In vitro 1O2 assay under
aerobic conditions, the relative absorbance of DPBF at 410 nm in the
solution changes with time. (D) Oxidative glutathione-like catalysis
of ZHTC@IR780 nanoparticles.The generated 1O2 from an
NIR-irradiated
ZHTC@IR780 nanoparticles solution without and with O2 was
measured by the degradation experiments of the 1,3-diphenylisobenzofuran
(DPBF) reagent. With the accumulation of light time, the absorption
value of the ZHTC@IR780 + DPBF solution at 410 nm decreased the most
(91.65%), which was significantly faster than the other three groups
of solutions (Figures B and S3A). It indicated the 1O2 production efficacy of the ZHTC@IR780 nanoparticles
solution was greatly improved due to more O2 supplementation
caused by the Fenton reaction. ZHTC@IR780 NPs had the function of
catalytic enzymes like H2O to catalyze H2O2 to continuously supplement
oxygen in solution, which promoted the production of 1O2. With the NIR-irradiated ZHTC@IR780 deaeration group as the
control, Figures C
and S4A showed that the absorbance drop
of DPBF at 410 nm (62.78%) was much smaller than that of the no deaeration
group. At the same time, compared to other controls, the ZHTC@IR780
nanoparticle solution had the best effect on 1O2 production.Next, we studied the role of ZHTC@IR780 nanoparticles
in the elimination
of glutathione in vitro. Using 5,5′-dithiobis-(2-nitrobenzoic
acid) (DTNB) as an indicator, GSH could react with it to form yellow
5-thio-2-nitrobenzoic acid. As can be seen from Figure D, DTNB had an obvious absorption peak at
323 nm. After GSH was added, the peak at 323 nm was significantly
weakened, and a new peak appeared at 408 nm, indicating the formation
of 5-thio-2-nitrobenzoic acid. However, if GSH first reacted with
ZHTC@IR780 nanoparticles for 10 min, it was found that GSH did not
react with DTNB, indicating that GSH was consumed by ZHTC@IR780 nanoparticles.
In addition, it was verified through experiments that ZHTC@IR780 nanoparticles
did not interact with DTNB. Based on all the abovementioned results,
it is proved that the ZHTC@IR780 nanoparticles also exhibited excellent
GSH depletion properties.
In Vitro Cellular Uptake of NPs and Production of ROS
The content of photosensitizers in cells is one of the important
factors that determine the effect of photodynamic therapy. The more
drugs that are endocytosed by cells, the more ROS will be produced
under light conditions. First, the amount of free IR780, ZHT@IR780,
ZCTC@IR780, and ZHTC@IR780 NPs internalized by CT26 cells was investigated
qualitatively by confocal microscopy. As shown in Figure A, a very weak fluorescence
signal was observed after cell incubation with free IR780 for 4 h,
suggesting that the free IR780 failed to efficiently enter CT26 cells.
The endocytosis of small molecular IR780 was significantly less than
that of drug-loaded nanoparticles. Furthermore, the endocytosis of
ZCTC@IR780 was lower than that of ZHT@IR780 and ZHTC@IR780 due to
the presence of hyaluronic acid, which could target the cellular protein
CD44 and increase the endocytosis of nanoparticles.[39−41] However, the
endocytosis of ZHT@IR780 and ZHTC@IR780 was basically the same. This
indicated that the ZHTC@IR780 possessed a good active-targeting ability
to enhance NP accumulation in the tumor.
Figure 4
(A) CLSM image of CT26
cells after 4 h of co-culture with IR780,
ZHT@IR780, ZCTC@IR780, and ZHTC@IR780. From left to right in each
column are the DAPI fluorescence of the nucleus, IR780 fluorescence,
Lyso-Tracker fluorescence of the lysosome, and the superposition of
all fluorescence. (B) CLSM observation of CT26 cells’ uptake
of small molecules IR780, ZHT@IR780, ZCTC@IR780, and ZHTC@IR780 and
the dark control group’s and light experimental group’s
ROS production.
(A) CLSM image of CT26
cells after 4 h of co-culture with IR780,
ZHT@IR780, ZCTC@IR780, and ZHTC@IR780. From left to right in each
column are the DAPI fluorescence of the nucleus, IR780 fluorescence,
Lyso-Tracker fluorescence of the lysosome, and the superposition of
all fluorescence. (B) CLSM observation of CT26 cells’ uptake
of small molecules IR780, ZHT@IR780, ZCTC@IR780, and ZHTC@IR780 and
the dark control group’s and light experimental group’s
ROS production.In the abovementioned processes, both H2O2 and GSH play important roles in yielding 1O2 and •OH, and the GSH depletion is
also good for
the existence of ROS. The ZHTC@IR780 NPs-mediated ROS (including both 1O2 and •OH) generation in CT26
cancer cells was tested with the intracellular 2,7-dichlorofluorescin
diacetate (DCFH-DA) probe to radiate green fluorescence with the oxidation
state. In Figure B,
compared with the other control groups, CT26 cells incubated with
ZHTC@IR780 nanoparticles posed stronger green fluorescence, while
ZHTC@IR780 and NIR-treated cells posed the strongest signal due to
the increased amount of ROS from the combined PDT and CDT effects.
However, the green fluorescence of ZCTC@IR780 was relatively weak,
which proved that ZHTC@IR780 had a targeted function. In addition,
the green fluorescence of ZHT@IR780 was not as good as that of ZHTC@IR780.
This is because the Fenton-like reaction could not take place, and
only small amounts of ROS were generated. Also, the green fluorescence
was the weakest in the small molecular IR780 group.
In Vitro Cytotoxicity Research
To evaluate the cytotoxicity
of ZHTC@IR780 NPs, we next used an MTT assay to analyze CT26 cells.
As shown in Figure , the cell viability of the irradiated and aerobic groups decreased
rapidly when the concentration of IR780 increased, demonstrating the
concentration-dependent cytotoxicity of IR780-based preparations.
Furthermore, ZHTC@IR780 exhibited obvious photodynamic cytotoxicity
to CT26 cells, which was greater than that of the IR780, ZHT@IR780,
and ZCTC@IR780 groups. The half-maximal inhibitory concentration (IC50) in the light and aerobic ZHTC@IR780 groups was 0.8864 μg/mL
for IR780, much lower than that of other groups. However, the anaerobic
group did not reach the half-maximal inhibitory dose regardless of
the 808 nm laser.
Figure 5
CT26 cell pairs ZHT@IR780, ZCTC@IR780, and ZHTC@IR780
in light
cell survival rate after 48 h of treatment at 37 °C with aerobic
(A), nonlight and aerobic (B), light and anaerobic (C), and nonlight
and anaerobic (D) treatments.
CT26 cell pairs ZHT@IR780, ZCTC@IR780, and ZHTC@IR780
in light
cell survival rate after 48 h of treatment at 37 °C with aerobic
(A), nonlight and aerobic (B), light and anaerobic (C), and nonlight
and anaerobic (D) treatments.
HIF-1α and PD-L1 Expression in Tumor Cells following Treatment
with ZHTC@IR780 NPs
The effective relief of tumor hypoxia
was also confirmed by measuring the expression of HIF-1α.[42] According to the in vitro results, ZHTC@IR780-triggered
generation of O2 with H2O2 after
laser irradiation might be helpful to relieve tumor hypoxia. Results
as shown in Figure A, through Western blot analysis, could be seen that the expression
of the ZHTC@IR780 group was the least, which was consistent with the
result of CLSM. The relief of tumor hypoxia is a key factor in improving
the therapeutic efficiency of PDT and inhibiting tumor metastasis.
Figure 6
(A) CLSM
observation of CT26 cells’ uptake of small molecules
IR780, ZHT@IR780, ZCTC@IR780, and ZHTC@IR780 and changes in intracellular
PD-L1 and HIF-1α. (B) Western blot analysis of the changes in
PD-L1 and HIF-1 expression levels of different treatments. (C) CLSM-measured
calcium reticulin outgrowth and HMGB1 content in the nucleus of CT26
cells after uptake of small molecules IR780, ZHT@IR780, ZCTC@IR780,
and ZHTC@IR780 under dark and light conditions.
(A) CLSM
observation of CT26 cells’ uptake of small molecules
IR780, ZHT@IR780, ZCTC@IR780, and ZHTC@IR780 and changes in intracellular
PD-L1 and HIF-1α. (B) Western blot analysis of the changes in
PD-L1 and HIF-1 expression levels of different treatments. (C) CLSM-measured
calcium reticulin outgrowth and HMGB1 content in the nucleus of CT26
cells after uptake of small molecules IR780, ZHT@IR780, ZCTC@IR780,
and ZHTC@IR780 under dark and light conditions.PD-L1 is highly expressed on the surface of tumor
cells. The purpose
of this study was to investigate the effect of improving tumor hypoxia
on the expression of PD-L1. From Figure B, it could be seen that under normal oxygen
conditions, tumor cells in the normal saline group expressed a certain
amount of PD-L1, and under hypoxia conditions, saline, small molecular
IR780, and ZHT@IR780 tumor cells highly expressed PD-L1. Although
the ZCTC@IR780 group can produce a Fenton-like reaction and relieve
hypoxia in tumor cells, the effect is generally owing to the small
amount of endocytosis. Compared with cells cultured under other hypoxia
conditions, the expression of PD-L1 in the cells co-incubated with
ZHTC@IR780 was low, indicating that it could alleviate the hypoxia
state of tumor cells. In addition, Western blot results showed that
the expression level of the ZHTC@IR780 group was the lowest, which
was in accordance with that of CLSM (Figure B).
Effect of PDT-Induced ICD
We tried to investigate the
effect of photodynamic therapy (PDT)-induced ICD by measuring the
expression of calreticulin (CRT) and the release of high mobility
histone 1 (HMGB1). CLSM results showed that only a little induced
CRT was exposed to the surface of CT26 cells in the unirradiated group.
On the contrary, the combination of ZCTC@IR780 and ZHTC@IR780 with
laser irradiation significantly promoted the expression of CRT (Figure C).HMGB1 is
a known danger signal that stimulates DC to engulf dying tumor cells. Figure C showed that HMGB1
was mainly located in the nucleus of CT26 incubated with saline, ZHT@IR780,
and ZCTC@IR780. Both PDT in the ZHT@IR780 + L and ZCTC@IR780 + L groups
could induce the moderate release of HMGB1. In contrast, HMGB1 was
almost completely released from the nucleus in the ZHTC@IR780 group.
In conclusion, the data from CRT exposure and HMGB1 release secretion
confirmed the accumulation of ICD induced by ZHTC@IR780-based PDT
in vitro.
Conclusions
In summary, zein, a natural protein of
plant origin, has greater
advantages over other synthetic polymers used in controlled drug and
biomedical delivery systems due to its safety and biocompatibility.
Here, we fabricated multifunctional nanoparticles using zein/hyaluronate
acid (HA)/tannin (TA)/Cu2+ loading them with IR780 (ZHTC@IR780),
which has high tumor cell targeting and catalytic action of catalase
(CAT)-like and glutathione peroxidase-like activities. In addition,
Zein-HA-TA-Cu@IR780 nanoparticles have good photodynamic and chemical
kinetic effects and can undergo Fenton-like reactions to catalyze
the production of cytotoxic hydroxyl radicals (•OH) from H2O2 as well as the production of
single-linear oxygen (1O2) by near-infrared
light. 808 nm laser irradiation can produce singlet oxygen (1O2). The good photodynamic and the chemical kinetic effects
of Zein-HA-TA-Cu@IR780 nanoparticles were verified at the nanoparticle
aqueous solution level as well as at the cellular level. The endocytosis
assay of nanoparticles by cells observed by laser confocal microscopy
showed that Zein-HA-TA-Cu@IR780 nanoparticles were mostly taken up
by cells, which verified that Zein-HA-TA-Cu@IR780 nanoparticles have
a targeting function. However, this research is to investigate the
killing effect on mouse colorectal cancer cells and its mechanism
at the cellular level. Further research is needed on the antitumor
effect at the animal level.
Authors: Jonathan G Hiller; Nicholas J Perry; George Poulogiannis; Bernhard Riedel; Erica K Sloan Journal: Nat Rev Clin Oncol Date: 2017-12-28 Impact factor: 66.675